Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7M Buy
484,403
+11,541
+2% +$302K 0.44% 35
2026
Q1
$13.3M Buy
472,862
+27,212
+6% +$724K 0.56% 23
2025
Q4
$11.1M Sell
445,650
-11,444
-3% -$289K 0.47% 31
2025
Q3
$11.6M Buy
457,094
+23,111
+5% +$570K 0.5% 25
2025
Q2
$10.5M Buy
433,983
+67,441
+18% +$1.57M 0.49% 26
2025
Q1
$9.29M Buy
366,542
+34,740
+10% +$909K 0.5% 31
2024
Q4
$8.8M Buy
331,802
+52,771
+19% +$1.43M 0.65% 25
2024
Q3
$8.08M Sell
279,031
-48,074
-15% -$1.4M 0.96% 25
2024
Q2
$9.15M Buy
327,105
+83,136
+34% +$2.29M 0.77% 20
2024
Q1
$6.77M Buy
243,969
+27,934
+13% +$775K 0.58% 36
2023
Q4
$6.22M Buy
216,035
+9,360
+5% +$283K 0.6% 38
2023
Q3
$6.86M Buy
206,675
+106,124
+106% +$3.75M 0.75% 30
2023
Q2
$3.69M Buy
100,551
+1,438
+1% +$56K 0.39% 45
2023
Q1
$4.04M Buy
99,113
+70,163
+242% +$3.03M 0.43% 45
2022
Q4
$1.48M Buy
28,950
+2,053
+8% +$98.4K 0.17% 75
2022
Q3
$1.18M Sell
26,897
-174
-0.6% -$8.46K 0.15% 83
2022
Q2
$1.42M Sell
27,071
-3,645
-12% -$186K 0.17% 85
2022
Q1
$1.59M Sell
30,716
-116,058
-79% -$6.02M 0.18% 77
2021
Q4
$8.67M Buy
146,774
+13,648
+10% +$676K 0.99% 14
2021
Q3
$5.73M Buy
133,126
+1,739
+1% +$77K 0.71% 16
2021
Q2
$5.14M Buy
131,387
+9,421
+8% +$366K 0.68% 21
2021
Q1
$4.42M Buy
121,966
+11,130
+10% +$395K 0.64% 22
2020
Q4
$4.08M Buy
110,836
+698
+0.6% +$25.6K 0.63% 16
2020
Q3
$3.83M Sell
110,138
-4,529
-4% -$159K 0.67% 14
2020
Q2
$3.56M Sell
114,667
-5,164
-4% -$175K 0.66% 17
2020
Q1
$3.71M Buy
119,831
+19,313
+19% +$658K 0.81% 15
2019
Q4
$3.74M Buy
100,518
+89,355
+800% +$3.18M 0.68% 19
2019
Q3
$381K Sell
11,163
-264
-2% -$9.6K 0.07% 116
2019
Q2
$470K Sell
11,427
-120
-1% -$4.76K 0.11% 104
2019
Q1
$465K Sell
11,547
-82,187
-88% -$3.29M 0.12% 102
2018
Q4
$3.88M Sell
93,734
-3,585
-4% -$149K 1.19% 7
2018
Q3
$4.07M Sell
97,319
-6,124
-6% -$236K 1.25% 9
2018
Q2
$3.56M Sell
103,443
-4,579
-4% -$156K 1.1% 12
2018
Q1
$3.64M Buy
108,022
+11
+0% +$378 1.16% 13
2017
Q4
$3.71M Sell
108,011
-20,929
-16% -$714K 1.04% 11
2017
Q3
$4.37M Sell
128,940
-1,084
-0.8% -$34.8K 1.27% 10
2017
Q2
$4.14M Buy
130,024
+3,334
+3% +$105K 1.47% 9
2017
Q1
$4.11M Buy
126,690
+5,074
+4% +$160K 1.53% 9
2016
Q4
$3.75M Buy
121,616
+112,142
+1,184% +$3.42M 1.46% 11
2016
Q3
$304K Sell
9,474
-1,027
-10% -$34.3K 0.19% 89
2016
Q2
$351K Sell
10,501
-640
-6% -$20.4K 0.2% 81
2016
Q1
$313K Sell
11,141
-3,578
-24% -$102K 0.2% 80
2015
Q4
$451K Sell
14,719
-386
-3% -$12.1K 0.32% 68
2015
Q3
$450K Sell
15,105
-411
-3% -$13.2K 0.36% 98
2015
Q2
$494K Sell
15,516
-1,635
-10% -$53.3K 0.37% 101
2015
Q1
$566K Sell
17,151
-105
-0.6% -$3.34K 0.4% 101
2014
Q4
$510K Sell
17,256
-534
-3% -$15.3K 0.35% 105
2014
Q3
$499K Sell
17,790
-1,263
-7% -$35.4K 0.36% 111
2014
Q2
$537K Sell
19,053
-4,839
-20% -$138K 0.38% 110
2014
Q1
$728K Sell
23,892
-7,466
-24% -$223K 0.49% 92
2013
Q4
$911K Sell
31,358
-36,373
-54% -$1.06M 0.47% 85
2013
Q3
$1.85M Sell
67,731
-5,988
-8% -$163K 0.65% 57
2013
Q2
$1.96M Buy
+73,719
New +$2.04M 0.69% 54

Other funds holding PFE

Bell Bank's PFE Position: Q2 2026 in Review

Bell Bank increased its Pfizer (PFE) stake by 2.4% in Q2 2026, buying an estimated $302K and bringing the position to 484,403 shares worth $11.7M. The position accounts for 0.44% of the portfolio, ranked #35.

Bell Bank first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.3M in Q1 2026. 495 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bell Bank held 484,403 shares of Pfizer worth $11.7M as of Q2 2026.
  • Bell Bank bought 11,541 Pfizer shares in Q2 2026, an estimated $302K.
  • Pfizer made up 0.44% of Bell Bank's portfolio in Q2 2026, its #35 holding.
  • Bell Bank first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Bell Bank's Pfizer position peaked at $13.3M in Q1 2026.
  • 495 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bell Bank's 13F filing for Q2 2026, filed 16 Jul 2026.